AstraZeneca: ‘Firing On All Cylinders’ In Q3
But UK Drug Maker Warns China Growth Will Now Slow
Executive Summary
AstraZeneca beat market forecasts when posting its fifth successive quarter of revenue growth – but the UK drug maker warned that its sales in China will now slow down.